Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies

Cancer Research - United States
doi 10.1158/0008-5472.can-16-2593
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction To: Role of Bruton’s Tyrosine Kinase in B Cells and Malignancies

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

MerReceptor Tyrosine Kinase Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Role of Calcium-Sensitive Tyrosine Kinase Pyk2/Cak /RAFTK in Angiotensin II Induced Ras/Erk Signaling

Hypertension
Internal Medicine
1998English

STAT Signaling in the Pathogenesis and Treatment of Leukemias

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

NR2B-NMDA Receptor-Mediated Increases in Intracellular Ca2+ Concentration Regulate the Tyrosine Phosphatase, STEP, and ERK MAP Kinase Signaling

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2010English

SRC Tyrosine Kinase Activation by 4-Hydroxynonenal Upregulates P38, ERK/AP-1 Signaling and COX-2 Expression in YPEN-1 Cells

PLoS ONE
Multidisciplinary
2015English

Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Metastatic Adamantinoma Responds to Treatment With Receptor Tyrosine Kinase Inhibitor

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2010English

Patient-Driven Discontinuation of Tyrosine Kinase Inhibitors: Single Institution Experience

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy